These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29089191)

  • 21. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59 months of age: A phase 3, randomized, noninferiority study.
    Statler VA; Albano FR; Airey J; Sawlwin DC; Graves Jones A; Matassa V; Heijnen E; Edelman J; Marshall GS
    Vaccine; 2019 Jan; 37(2):343-351. PubMed ID: 30057283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis.
    de Lusignan S; Dos Santos G; Byford R; Schuind A; Damaso S; Shende V; McGee C; Yonova I; Ferreira F
    Adv Ther; 2018 Aug; 35(8):1199-1214. PubMed ID: 29995300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
    Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases.
    Esteban-Vasallo MD; Domínguez-Berjón MF; García-Riolobos C; Zoni AC; Aréjula Torres JL; Sánchez-Perruca L; Astray-Mochales J
    Vaccine; 2019 Aug; 37(36):5257-5264. PubMed ID: 31353257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy.
    Regan AK; Tracey LE; Blyth CC; Richmond PC; Effler PV
    Vaccine; 2016 Apr; 34(20):2299-304. PubMed ID: 27038132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving Rates of Outpatient Influenza Vaccination Through EHR Portal Messages and Interactive Automated Calls: A Randomized Controlled Trial.
    Cutrona SL; Golden JG; Goff SL; Ogarek J; Barton B; Fisher L; Preusse P; Sundaresan D; Garber L; Mazor KM
    J Gen Intern Med; 2018 May; 33(5):659-667. PubMed ID: 29383550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaxtracker: Active on-line surveillance for adverse events following inactivated influenza vaccine in children.
    Cashman P; Moberley S; Dalton C; Stephenson J; Elvidge E; Butler M; Durrheim DN
    Vaccine; 2014 Sep; 32(42):5503-8. PubMed ID: 25077424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
    Treanor JT; Albano FR; Sawlwin DC; Graves Jones A; Airey J; Formica N; Matassa V; Leong J
    Vaccine; 2017 Apr; 35(15):1856-1864. PubMed ID: 28302411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women.
    Regan AK; Tracey L; Blyth CC; Mak DB; Richmond PC; Shellam G; Talbot C; Effler PV
    BMC Pregnancy Childbirth; 2015 Mar; 15():61. PubMed ID: 25880741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.
    Dos Santos G; Nguyen BY; Damaso S; Godderis L; Martínez-Gómez X; Eckermann T; Loos H; Salamanca de la Cueva I; Shende V; Schmidt AC; Yeakey A
    Drug Saf; 2020 Mar; 43(3):265-279. PubMed ID: 31884676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Ownership Text Message Wording and Reminders on Receipt of an Influenza Vaccination: A Randomized Clinical Trial.
    Buttenheim A; Milkman KL; Duckworth AL; Gromet DM; Patel M; Chapman G
    JAMA Netw Open; 2022 Feb; 5(2):e2143388. PubMed ID: 35175346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using Technology to Affect Influenza Vaccine Coverage Among Children With Chronic Respiratory Conditions.
    Bay SL; Crawford DJ
    J Pediatr Health Care; 2017; 31(2):155-160. PubMed ID: 27475928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Texting- and Internet-Based Self-Reporting System for Enhanced Vaccine Safety Surveillance With Insights From a Large Integrated Health Care System in the United States: Prospective Cohort Study.
    Malden DE; Gee J; Glenn S; Li Z; Ryan DS; Gu Z; Bezi C; Kim S; Jazwa A; McNeil MM; Weintraub ES; Tartof SY
    JMIR Mhealth Uhealth; 2024 Oct; 12():e58991. PubMed ID: 39393058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of live-attenuated influenza vaccination in cystic fibrosis.
    Boikos C; De Serres G; Lands LC; Boucher FD; Tapiéro B; Daigneault P; Quach C
    Pediatrics; 2014 Oct; 134(4):e983-91. PubMed ID: 25225145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized Controlled Trial of Text Message Reminders for Increasing Influenza Vaccination.
    Regan AK; Bloomfield L; Peters I; Effler PV
    Ann Fam Med; 2017 Nov; 15(6):507-514. PubMed ID: 29133488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Gorse GJ; Falsey AR; Ozol-Godfrey A; Landolfi V; Tsang PH
    Vaccine; 2015 Feb; 33(9):1151-9. PubMed ID: 25613721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season.
    Tennis P; Toback SL; Andrews EB; McQuay LJ; Ambrose CS
    Vaccine; 2012 Sep; 30(42):6099-102. PubMed ID: 22841479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.
    Gaglani MJ; Piedra PA; Riggs M; Herschler G; Fewlass C; Glezen WP
    Pediatr Infect Dis J; 2008 May; 27(5):444-52. PubMed ID: 18401289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.